Cell therapy company Gamida Cell will be forced to go private after failing to find a partner for its cell therapy product Omisirge (omidubicel-onlv), which won 28 March 2024
In California, an artificial intelligence-based protein design company called Profluent has added $35 million to its financing, with money being put forward by 25 March 2024
Capstan Therapeutics, a company advancing in vivo reprogramming of cells through RNA delivery using targeted lipid nanoparticles, has become the latest San Dieg 21 March 2024
Another start-up has launched in the bustling biotech hub around Boston, USA, with $150 million in financing from investors including Novo Holdings. 21 March 2024
San-Diego Contineum Therapeutics, biotech developing small molecule therapies for the treatment of neuroscience, inflammation, and immunology (NI&I) indications 19 March 2024
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.